Help | RSS Feed

Emerald Bioscience Inc. (OTCMKT:EMBI) Seasonal Chart

Seasonal Chart Analysis

Analysis of the Emerald Bioscience Inc. (OTCMKT:EMBI) seasonal charts above shows that a Buy Date of March 10 and a Sell Date of June 5 has resulted in a geometric average return of 11.36% above the benchmark rate of the S&P 500 Total Return Index over the past 6 years. This seasonal timeframe has shown positive results compared to the benchmark in 4 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 6 years by an average of 74.77% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

A word of caution: Only 6 years of data is available for shares of EMBI, perhaps insufficient to create a seasonal profile that accurately gauges the seasonal tendencies influencing the investment. Ideally, while 20 years is preferred, at least 10 years of data is required to perform a seasonal analysis that is considered to be reliable for future seasonal periods.

Emerald Bioscience Inc is a life science biopharmaceutical company. It is engaged in the discovery, development, and the commercialization of cannabinoid-based therapeutics. The company is focused on the development of early-stage cannabinoid product candidates which includes NB1111 for the treatment of glaucoma, and NB2222 for treatment and management of several eye diseases, including uveitis, dry eye syndrome, macular degeneration and diabetic retinopathy; and NB3111.

To download EMBI seasonal chart data, please log in or Subscribe.


Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z